Let's hear about the Oyster!

[anonymous]

The ones who actually add value were spared
Glad OP made the necessary changes
Be grateful

Feeling good now…finally. with Sniz off our back I feel better
Genentech didn’t want him
Takeda didn’t want him
Novartis didn’t want him
Oyster Point didn’t want him

I’m sleeping peacefully and motivated tonight knowing that he’s not a part of this company

 

[anonymous]

If you are calling the purchase and execution of Xiidra successful by Novartis you have no idea on how a business should be run. Flat share for 3 years at 5.3 BILLION?

The launch of this product is going fine. Education is the main thing and top doctors who use the drug see the benefit. More data to come as well.....

Actually, Xiidra had the highest market share in Medicaid. Plus they aren’t the preferred drug on the Medicaid formulary. So, get a life and get to work

 

[anonymous]

Well tell us this how profitable is your Medicaid high market share? Actually let me tell you, not much at all